Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

PR Newswire June 9, 2021

Canadian Medical Auctions Launches First Auction in Toronto, Canada

Canada NewsWire June 9, 2021

Ambius Launches VIRUSKILLER(TM) to Provide Complete Indoor Air Safety

PR Newswire June 9, 2021

NUWAY® Designated as a Blue Distinction® Center for Substance Use Treatment and Recovery

PR Newswire June 9, 2021

Oregon House Telemedicine Bill 2508A Passes with ZoomCare Support

PR Newswire June 9, 2021

The Pancreatic Cancer Action Network Increases Biomarker-Driven Clinical Trial Matching Capabilities by nearly 300% with GenomOncology

PR Newswire June 9, 2021

Zocdoc Announces "A Year in Hybrid Care," Unveiling Appointment Booking Trends That Point to a Return to In-Person Care

PR Newswire June 9, 2021

EMBARGOED RELEASE: U.S. and Canadian Workers' Stress Levels Skyrocketed During the Pandemic, Despite Higher Levels of Employee Engagement

Canada NewsWire June 9, 2021

Allara Launches First and Only Collaborative Care Platform to Address and Empower the Millions of Women with PCOS

PR Newswire June 9, 2021

Texas Children's Hospital Center for Vaccine Development COVID-19 Subunit Vaccine Candidate Advancing Towards Global Access

PR Newswire June 9, 2021

Digital health leader PeerWell adds Dr. Jonathan Slotkin to the Board of Directors and launches its whole-person clinical practice for musculoskeletal care

PR Newswire June 9, 2021

Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters

PR Newswire June 9, 2021

Midol® Launches Initiative to Help Women Stop Apologizing. Period.

PR Newswire June 9, 2021

OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James

Canada NewsWire June 9, 2021

Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer

PR Newswire June 9, 2021

XS Brokers Taps Kevin Mordarski to Lead its New Healthcare Practice

PR Newswire June 9, 2021

COPIKTRA® (duvelisib) Receives European Union Marketing Authorization for the Treatment of Relapsed or Refractory CLL and Refractory FL

PR Newswire June 9, 2021

Synaptogenix Announces Phase 2b NIH Sponsored Alzheimer's Disease Trial Update

PR Newswire June 9, 2021

Advarra Announces Key Growth Milestone for The Gene Therapy Ready Network, Becoming Largest IBC Service

PR Newswire June 9, 2021

DURECT Corporation to Present Additional Clinical Data from DUR-928 Studies in NASH (Phase 1b) and in Hepatic Impairment (Phase 1) at Upcoming International Liver Conference 2021 (EASL)

PR Newswire June 9, 2021